Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableTemporarily pausedNCT05567692
What this trial is testing

Subjects With T2D or at Risk of T2D Cohort Follow-up

Who this might be right for
Diabetes Mellitus, Type 2
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète 837
Large-scale testing (Phase 3)Study completedNCT02505334
What this trial is testing

A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 635
Testing effectiveness (Phase 2)Study completedNCT01213212
What this trial is testing

Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk

Who this might be right for
Diabetes Mellitus
Mario Negri Institute for Pharmacological Research 73
Large-scale testing (Phase 3)Ended earlyNCT00865592
What this trial is testing

Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusType 2 Diabetes
Phenomix 450
Testing effectiveness (Phase 2)Study completedNCT03560271
What this trial is testing

Cyclo-Z in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
NovMetaPharma Co., Ltd. 256
Post-approval studies (Phase 4)Study completedNCT00998335
What this trial is testing

Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Florida 30
Large-scale testing (Phase 3)Study completedNCT01505426
What this trial is testing

Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

Who this might be right for
Type II Diabetes Mellitus
Astellas Pharma Inc 171
Testing effectiveness (Phase 2)Study completedNCT01230749
What this trial is testing

Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 89
Testing effectiveness (Phase 2)Study completedNCT01788033
What this trial is testing

Effects of XOMA 052 on Insulin Production in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus Type 1
University of Zurich 22
Large-scale testing (Phase 3)Study completedNCT01474538
What this trial is testing

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 122
Early research (Phase 1)Study completedNCT05719155
What this trial is testing

Pharmacokinetics and Safety/Tolerability of CKD-379

Who this might be right for
Type II Diabetes Mellitus
Chong Kun Dang Pharmaceutical 32
Early research (Phase 1)Study completedNCT00886821
What this trial is testing

A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 114
Testing effectiveness (Phase 2)Study completedNCT03444584
What this trial is testing

Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
MedImmune LLC 49
Testing effectiveness (Phase 2)Study completedNCT00231647
What this trial is testing

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

Who this might be right for
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113
Testing effectiveness (Phase 2)Study completedNCT00291356
What this trial is testing

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2Non-Insulin-Dependent Diabetes Mellitus
GlaxoSmithKline 45
Large-scale testing (Phase 3)Study completedNCT01456195
What this trial is testing

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 421
Post-approval studies (Phase 4)Study completedNCT00686712
What this trial is testing

Insulin Glargine at Bedtime or in AM Versus NPH

Who this might be right for
Type 2 Diabetes Mellitus
Charles Drew University of Medicine and Science 108
Large-scale testing (Phase 3)Study completedNCT00504673
What this trial is testing

Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 277
Large-scale testing (Phase 3)Ended earlyNCT00427154
What this trial is testing

Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 227
Early research (Phase 1)Study completedNCT02058641
What this trial is testing

Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Atherosclerosis
GlaxoSmithKline 9
Next Page